Vulnerability Description
A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the interface of an affected device. The vulnerability exists because the web-based management interface does not properly validate user-supplied input. An attacker could exploit this vulnerability by persuading a user to click a crafted link. A successful exploit could allow the attacker to execute arbitrary script code in the context of the interface or access sensitive, browser-based information. To exploit this vulnerability, an attacker would need to have administrative credentials on the affected device.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Cisco | Catalyst Center | < 2.2.1.0 |
Related Weaknesses (CWE)
References
- https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-dVendor Advisory
- https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-dVendor Advisory
FAQ
What is CVE-2021-1130?
CVE-2021-1130 is a vulnerability with a CVSS score of 4.8 (MEDIUM). A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the in...
How severe is CVE-2021-1130?
CVE-2021-1130 has been rated MEDIUM with a CVSS base score of 4.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2021-1130?
Check the references section above for vendor advisories and patch information. Affected products include: Cisco Catalyst Center.